USFDA lifts clinical hold on Opella’s planned actual use trial to switch Cialis from prescription to OTC Read more
Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS Read more
Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Read more
Lupin launches Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the US Read more
Zydus signs agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to its template formulary Read more
